GEORGIA PEDIATRIC ENDOCRINE

VIRTUAL CONFERENCE

FRIDAY,

NOVEMBER 20, 2020

VIRTUAL EXHIBIT HALL

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
8d24929b0ebd57e691ea9db331e1c1fa-youtube
8d24929b0ebd57e691ea9db331e1c1fa-youtube

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

 

For more information about AbbVie, please visit us at www.abbvie.com.

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG).

For more information about Alexion, visit alexion.com.

Arbor Pharmaceuticals is led by a team of skilled pharmaceutical veterans, many of whom have experience as healthcare practitioners. Our people fully understand the pharmaceutical development process and value our products can bring to the lives of patients. The Arbor team is now over 300 strong and has full knowledge and capabilities in pharmaceutical research and development, manufacturing, quality control and market commercialization. We work with numerous partners throughout the world for the licensing, manufacturing or development of our marketed and late stage pipeline products.

Arbor Pharmaceuticals has established the goal of becoming the largest privately owned U.S. pharmaceutical company. We are currently working with many of the local universities and discovery centers to identify and keep those innovations in the Atlanta economy through partnerships with Arbor. Our focus is on identifying opportunities that offer improved outcomes for our patients.

For more information, visit arborpharma.com.

At Endo International, our generics and specialty branded products play an important role in helping millions of patients lead healthier lives.

 

Through our operating companies, we are dedicated to delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization.

For more information about Endo, visit endo.com.

Ipsen Biopharmaceuticals, Inc. is a US affiliate of Ipsen SA, a global biotech company. At Ipsen Biopharmaceuticals, we are focused on developing and providing access to therapies for patients who suffer from extremely difficult-to-treat diseases.

 

For more information on Ipsen in North America, please visit www.ipsenus.com

 

Human Growth
Foundation

Headquarters:

997 Glen Cove Ave, Suite 5

Glen Head, New York 11545 USA

Email: hgf1@hgfound.org

Telephone: 1-800-451-6434

Fax Number: 1-516-671-4055

Human Growth Foundation (HGF)

is a  501(c)(3) non-profit organization.

 

Federal Tax Identification# 16-0913012  

Get HGF Updates

© 2020 by Human Growth Foundation. Created by D. Plump Consulting